Convergys Corporation (NYSE:CVG) announced that Cincinnati Bell Inc. (NYSE:CBB), one of the United States’ most respected and best performing local exchange and wireless providers, has implemented Convergys Intelligent Credits Solution, which will help Cincinnati Bell deliver the right customer credits at the right time to its valued customers. “The Convergys solution will enable us to further enhance our customer service experience through consistent policy application while helping us achieve cost savings for our business,” said Tara Khoury, CMO, Cincinnati Bell.
Convergys Corporation provides relationship management solutions worldwide. The company's Customer Management segment provides agent-assisted services, including customer acquisition, customer retention, technical support, back office, and business-to-business services. This segment also offers intelligent interaction solutions comprising technologies, such as voice portals and speech automation, real-time decisioning, Web-based service channels, identity verification, mobile services, and enhanced analytics.
First Trust/Aberdeen Global Opportunity Income Fund (NYSE:FAM) declared the Fund’s regularly scheduled monthly common share distribution payable on January 14, 2011 to shareholders of record as of January 5, 2011. The ex-dividend date is expected to be January 3, 2011. The monthly distribution information for the Fund appears: Distribution per share: $0.13; Distribution Rate based on the December 17, 2010 NAV of $17.54: 8.89%; Distribution Rate based on the December 17, 2010 closing market price of $16.50: 9.45%.
First Trust Portfolios L.P., are privately-held companies which provide a variety of investment services, including asset management, financial advisory services, and municipal and corporate investment banking, with collective assets under management or supervision of approximately $39 billion as of November 30, 2010 through closed-end funds, unit investment trusts, mutual funds, separate managed accounts and exchange-traded funds.
Power3 Medical Products, Inc. (OTC:PWRM)
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. Power3 Medical works with key physician scientists at major medical research and treatment centers.
With access to decisive human clinical samples and superior trade secret proteomic methodologies, the Company provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents.
Power3 is also adding additional layers of research and license agreements, patent filings, and trade secrets, as its technology and product portfolio develops.
Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced recently that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD ) in Honolulu, Hawaii.These presentations discussed NuroPro®, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.Alzheimer’s disease isn’t an ordinary part of getting older, even though greatest known risk factor is increasing age, along with the largest part of people today with Alzheimer’s tend to be 65 and older.
But Alzheimer’s is not just a sickness of old age.
Up to 5 % of people with the sickness currently have early-onset Alzheimer’s (also referred to as younger-onset), which frequently appears when ever someone is within his or her 40s or 50s.
Power3 has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.
To learn more about PWRM visit: http://www.Power3Medical.com
Orofino Gold Corp. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.
La Azul - Senderos de Oro Area
La Azul is one producing artesanal mine in the Senderos de Oro area controlled by ORFG, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens.
It has been interpreted (by Shaw 1993) that the metallogenic zonation around the La Azul workings evokes a very viable "hidden porphyry" exploration model. This interpretation and the prospectivity of the area have been confirmed by the Orofino "qualified person" as per the 43-101 rules.
ORFG will move ahead aggressively in the last quarter of 2010 to persue the current interpretations, work programs and drilling will begin soon.
Orofino Gold Corp. engages in acquisition, exploration, and development of gold properties in Mexico and Colombia. ORFG has an option to acquire properties in the Sur de Bolivar Department of Colombia South America. ORFG was formerly known as SNT Cleaning, Inc. and changed its name to Orofino Gold Corp. in December 2009. ORFG was founded in 2005 and is based in Central, Hong Kong.
To learn about ORFG visit: http://www.orofinogold.com
Chemtura Corp. Common Stock (NYSE:CHMT) announced that it is raising the price of the products supplied by the Antioxidant and UV Stabilizer business, primarily as the result of a significant and sustained increase in key raw material costs. Effective on all deliveries after Jan. 1, 2011, or as contracts allow, the price of the Antioxidant and UV Stabilizers will be increased by up to 15 percent. These increases are essential to sustain Chemtura as a viable supplier and to enable continued reinvestment.
Chemtura Corporation, together with its subsidiaries, engages in the manufacture and sale of specialty chemical solutions and consumer products worldwide. The company's Consumer Performance Products segment provides recreational water purification products, such as sanitizers, algaecides, biocides, oxidizers, pH balancers, mineral balancers, and other specialty chemicals and accessories; and specialty and multi-purpose cleaners.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.